Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-25T14:07:05.388Z Has data issue: false hasContentIssue false
  • English
  • Français

COVID vaccine-associated myocarditis in an 8-year-old patient

Published online by Cambridge University Press:  27 July 2022

Karina Mehta Open the ORCID record for Karina Mehta [Opens in a new window] ,
Richard Cohen ,
Brendan Kelly  and
Lars Grosse-Wortmann
Karina Mehta
Affiliation:
Oregon Health & Science University, Department of Pediatrics, Doernbecher Children’s Hospital, 700 S.W. Campus Drive, Portland, OR 97239, USA
Richard Cohen
Affiliation:
Oregon Health & Science University, Department of Pediatrics, Doernbecher Children’s Hospital, 700 S.W. Campus Drive, Portland, OR 97239, USA
Brendan Kelly
Affiliation:
Oregon Health & Science University, Department of Pediatrics, Doernbecher Children’s Hospital, 700 S.W. Campus Drive, Portland, OR 97239, USA
Lars Grosse-Wortmann*
Affiliation:
Oregon Health & Science University, Department of Pediatrics, Doernbecher Children’s Hospital, 700 S.W. Campus Drive, Portland, OR 97239, USA
*
Author for correspondence: Lars Grosse-Wortmann, MD, Department of Pediatrics, Doernbecher Children’s Hospital, 700 S.W. Campus Drive, Portland, OR 97239, USA. Tel: +1 503 346 0640. E-mail: grossewo@ohsu.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

COVID vaccine-associated myocarditis was first identified in March 2021. There have been numerous case reports that detail the clinical course of paediatric patients older than age 12 with COVID vaccine-associated myocarditis. There are still very few reports of children between the ages of 5 and 11 with COVID vaccine-associated myocarditis. We present an 8 year- old with COVID vaccine-associated myocarditis after his second vaccination against SARS-CoV-2.

Keywords

COVIDmyocarditisvaccine associated
Type
Brief Report
Information
Cardiology in the Young , Volume 33 , Issue 2 , February 2023 , pp. 334 - 335
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

The online version of this article has been updated since original publication. A notice detailing the change has also been published

References

FDA Approves First COVID-19 Vaccine | FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine. Accessed January 7, 2022.Google Scholar
Shimabukuro, T. Vaccines and Related Biological Products Advisory Committee June 10. In: 2021 Meeting Presentation – COVID-19 Vaccine Safety Updates, 2021 Google Scholar
Witberg, G, Barda, N, Hoss, S, et al. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med. 2021; 385: 2132–2139. DOI 10.1056/NEJMOA2110737.CrossRefGoogle Scholar
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age | FDA. https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age. Accessed January 10, 2022.CrossRefGoogle Scholar
Marshall, M, Ferguson, ID, Lewis, P, et al. Symptomatic acute myocarditis in 7 adolescents after pfizer-biontech covid-19 vaccination. Pediatrics 2021; 148: 2603. DOI 10.1542/PEDS.2021-052478/179728.CrossRefGoogle ScholarPubMed
Law, YM, Lal, AK, Chen, S, et al. Diagnosis and management of myocarditis in children: a scientific statement from the american heart association. Circulation 2021; 144: E123–E135. DOI 10.1161/CIR.0000000000001001.CrossRefGoogle ScholarPubMed
Jain, SS, Steele, JM, Fonseca, B, et al. Covid-19 vaccination-associated myocarditis in adolescents. Pediatrics 2021; 148: e2021053427. DOI 10.1542/PEDS.2021-053427.CrossRefGoogle ScholarPubMed
Truong, DT, Dionne, A, Muniz, JC, et al. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation December 2021, 10.1161/CIRCULATIONAHA.121.056583.Google ScholarPubMed
Lin, G-M, Yaser Hashemi, S, Wang, X, et al. Global regional, and national burden of myocarditis from 1990 to 2017: a systematic analysis based on the global burden of disease study 2017. Front Cardiovasc Med | www.frontiersin.org 2019; 1: 692990. DOI 10.3389/fcvm.2021.692990.Google Scholar
Dorabawila, V, Hoefer, D, Bauer, UE, Bassett, MT, Lutterloh, E, Rosenberg, ES. Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the emergence of the Omicron variant 2022; 385: 2241. DOI 10.1101/2022.02.25.22271454.CrossRefGoogle Scholar